Quality Payment Program Measures Data |
Back to Merit-based Incentive Payment System |
| Measure ID | NQF ID | National Quality Strategy Domain | Title | High Priority | Measure Type | Submission Methods | Speciality Measure Sets | |
|---|---|---|---|---|---|---|---|---|
| 147 | Communication and Care Coordination | Nuclear Medicine: Correlation with Existing Imaging Studies for All Patients Undergoing Bone Scintigraphy | Process | Claims | Registry | Diagnostic Radiology | Details | ||
| NPQR19 | Effective Clinical Care | Notification to the provider ordering repeat Hepatitis C serology testing on a patient with previously positive results | Process | Registry | Details | |||
| NPQR18 | Effective Clinical Care | Notification to the provider ordering repeat CBCs in clinically stable patients within four days | Process | Registry | Details | |||
| NPQR17 | Effective Clinical Care | Notification to the provider ordering repeat C. difficile stool toxin testing within seven days | Process | Registry | Details | |||
| NPQR16 | Effective Clinical Care | Notification to the provider ordering repeat blood chemistry panels in clinically stable patients within four days. | Process | Registry | Details | |||
| NPQR2 | Effective Clinical Care | Notification to the ordering provider requesting thyroid screening tests other than only a Thyroid Stimulating Hormone (TSH) test in the initial screening of a patient with a suspected thyroid disorder | Process | Registry | Details | |||
| NPQR1 | Effective Clinical Care | Notification to the ordering provider requesting myoglobin or CK-MB in the diagnosis of suspected acute myocardial infarction (AMI) | Process | Registry | Details | |||
| NPQR3 | Effective Clinical Care | Notification to the ordering provider requesting amylase testing in the diagnosis of suspected acute pancreatitis | Process | Registry | Details | |||
| NPQR15 | Effective Clinical Care | Non-small cell lung carcinoma (NSCLC) ancillary biomarker testing status and turnaround time (TAT) from point of specimen accession date to ancillary biomarker testing completion and reporting date should be ≤ 10 days | Process | Registry | Details | |||
| 443 | Patient Safety | Non-Recommended Cervical Cancer Screening in Adolescent Females | Process | Registry | Family Medicine | Internal Medicine | Obstetrics Gynecology | Details | ||
| ACMS7 | Patient Safety | Non-Opioid Pain Management Following Mohs micrographic surgery | Process | Registry | Details | |||
| AQUA16 | Effective Clinical Care | Non-Muscle Invasive Bladder Cancer: Repeat Transurethral Resection of Bladder Tumor (TURBT) for T1 disease | Process | Registry | Details | |||
| AQUA17 | Effective Clinical Care | Non-Muscle Invasive Bladder Cancer: Initiation of BCG within 3 months of diagnosis of high-grade T1 bladder cancer and/or CIS | Process | Registry | Details | |||
| AQUA18 | Effective Clinical Care | Non-Muscle Invasive Bladder Cancer: Early surveillance cystoscopy within 4 months of initial diagnosis | Process | Registry | Details | |||
| USWR23 | Effective Clinical Care | Non Invasive Arterial Assessment of patients with lower extremity wounds or ulcers for determination of healing potential | Process | Registry | Details | |||
| IGR11 | Efficiency and Cost Reduction | Myocardial Perfusion Imaging (MPI), Transthoracic Echocardiography (TTE), or Stress Echocardiography studies meeting appropriate use criteria | Efficiency | Registry | Details | |||
| IGR5 | Effective Clinical Care | Myocardial Perfusion Imaging (MPI) studies, Transthoracic Echo (TTE), or Stress Echocardiography imaging studies reporting Left Ventricular Ejection Fraction | Process | Registry | Details | |||
| IGR4 | Efficiency and Cost Reduction | Myocardial Perfusion Imaging (MPI) studies or Stress Echocardiography imaging studies not Equivocal | Efficiency | Registry | Details | |||
| ACRAD34 | Patient Safety | Multi-strata weighted average for 3 CT Exam Types: Overall Percent of CT exams for which Dose Length Product is at or below the size-specific diagnostic reference level (for CT Abdomen-pelvis with contrast/single phase scan, CT Chest without contrast/single phase scan and CT Head/Brain without contrast/single phase scan) | Outcome | Registry | Details | |||
| 477 | Effective Clinical Care | Multimodal Pain Management | Process | Registry | Anesthesiology | Details |